Author

Lindsey Overman

Institution: Sarcoma Alliance for Research through Collaboration

Observed institutions: Sarcoma Alliance for Research through Collaboration, University of Arkansas for Medical Sciences

ORCID: 0009-0008-6454-3035

Observed ORCID: 0009-0008-6454-3035

OpenAlex ID: A5088317639

Rationale and design of CH STRONG: Congenital Heart Survey To Recognize Outcomes, Needs, and well-beinG

2020 · Sherry L. Farr, Scott E. Klewer, et al. · American Heart Journal · 22

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial

2026 · Patrick J. Grohar, Rachel Heise, et al. · Nature Medicine · 1

SARC046: A phase II trial of nab-sirolimus in patients with progressing or symptomatic epithelioid hemangioendothelioma.

2026 · Michael J. Wagner, Karla V. Ballman, et al. · Journal of Clinical Oncology

Abstract 11112: Rationale and Design of Ch Strong: Congenital Heart Survey to Recognize Outcomes, Needs, and Well-beinG

2019 · Sherry L. Farr, Scott E. Klewer, et al. · Circulation

Works count: 4

Citation count: 23

H-index: 1

I10-index: 1